GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Cyclically Adjusted FCF per Share

Sci Pharmtech (TPE:4119) Cyclically Adjusted FCF per Share : NT$0.62 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sci Pharmtech's adjusted free cash flow per share for the three months ended in Mar. 2024 was NT$-0.191. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$0.62 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Sci Pharmtech's average Cyclically Adjusted FCF Growth Rate was -34.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -32.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sci Pharmtech was -29.10% per year. The lowest was -32.40% per year. And the median was -30.75% per year.

As of today (2024-06-23), Sci Pharmtech's current stock price is NT$90.30. Sci Pharmtech's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was NT$0.62. Sci Pharmtech's Cyclically Adjusted Price-to-FCF of today is 145.65.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sci Pharmtech was 200.39. The lowest was 27.26. And the median was 63.68.


Sci Pharmtech Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Sci Pharmtech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Cyclically Adjusted FCF per Share Chart

Sci Pharmtech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 2.07 1.59 0.50 0.64

Sci Pharmtech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 1.16 0.94 0.64 0.62

Competitive Comparison of Sci Pharmtech's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sci Pharmtech's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sci Pharmtech's Cyclically Adjusted Price-to-FCF falls into.



Sci Pharmtech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sci Pharmtech's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.191/131.7762*131.7762
=-0.191

Current CPI (Mar. 2024) = 131.7762.

Sci Pharmtech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.282 100.560 -0.370
201409 -0.651 100.428 -0.854
201412 -0.051 99.070 -0.068
201503 0.968 99.621 1.280
201506 0.502 100.684 0.657
201509 0.487 100.392 0.639
201512 2.128 99.792 2.810
201603 -0.082 100.470 -0.108
201606 0.908 101.688 1.177
201609 1.383 101.861 1.789
201612 1.256 101.863 1.625
201703 0.533 102.862 0.683
201706 -0.140 103.349 -0.179
201709 -0.403 104.136 -0.510
201712 1.226 104.011 1.553
201803 0.255 105.290 0.319
201806 0.937 106.317 1.161
201809 1.174 106.507 1.453
201812 0.540 105.998 0.671
201903 1.965 107.251 2.414
201906 0.385 108.070 0.469
201909 1.056 108.329 1.285
201912 1.937 108.420 2.354
202003 1.950 108.902 2.360
202006 1.897 108.767 2.298
202009 1.473 109.815 1.768
202012 1.562 109.897 1.873
202103 1.651 111.754 1.947
202106 -3.352 114.631 -3.853
202109 0.108 115.734 0.123
202112 -3.011 117.630 -3.373
202203 -5.833 121.301 -6.337
202206 2.151 125.017 2.267
202209 -1.569 125.227 -1.651
202212 -3.171 125.222 -3.337
202303 -4.204 127.348 -4.350
202306 1.831 128.729 1.874
202309 -2.315 129.860 -2.349
202312 -3.031 129.419 -3.086
202403 -0.191 131.776 -0.191

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Sci Pharmtech  (TPE:4119) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sci Pharmtech's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=90.30/0.62
=145.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sci Pharmtech was 200.39. The lowest was 27.26. And the median was 63.68.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sci Pharmtech Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sci Pharmtech (TPE:4119) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines